Cite
HARVARD Citation
Fujita, K. et al. (2021). A phase 2b, randomized, double‐blind, multicenter, vehicle‐controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild‐to‐moderate atopic dermatitis. Journal of dermatology. 48 (11), pp. 1640-1651. [Online].